Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

How to Choose a Biotechnology Consultant: Key Considerations for Success

Sep 19, 2025

Understanding the Role of a Biotechnology Consultant

Biotechnology consultants play a crucial role in guiding businesses through the complex landscape of biotechnology. Whether it's helping with regulatory compliance, research and development, or market entry strategies, these experts provide invaluable insights and support. Choosing the right biotechnology consultant can be the difference between success and failure in this rapidly evolving industry.

biotechnology consultant

Assessing Industry Experience and Expertise

When selecting a biotechnology consultant, one of the first things to consider is their industry experience and expertise. A consultant with extensive experience in your specific area of biotechnology is more likely to understand the unique challenges and opportunities that your business faces. Look for a track record of successful projects and satisfied clients as an indicator of their capability.

Additionally, consider the consultant's background in both academia and industry. A strong academic foundation combined with practical industry experience can provide a well-rounded perspective, offering both theoretical and applied insights.

Evaluating Communication and Interpersonal Skills

Effective communication is essential for a successful consultancy relationship. A good biotechnology consultant should be able to clearly articulate complex scientific concepts in a way that is understandable to all stakeholders involved. They should also possess excellent interpersonal skills to foster collaboration and trust within your team.

team meeting

During the selection process, pay attention to how the consultant interacts with you and your team. Are they responsive, approachable, and open to feedback? These qualities are critical for ensuring smooth and productive collaboration throughout your project.

Understanding Regulatory Knowledge

The biotechnology sector is heavily regulated, and compliance with these regulations is non-negotiable. A competent biotechnology consultant should have a deep understanding of the relevant regulatory environment, including FDA, EMA, or other regional regulations pertinent to your product or service.

  • Ensure they have experience with regulatory submissions and approvals.
  • Check their familiarity with quality assurance processes.
  • Verify their understanding of intellectual property considerations.
regulatory compliance

Considering Cost and Value

Cost is always a factor when hiring a consultant, but it's important to assess the value they bring to your business. Instead of focusing solely on fees, consider how their expertise can help you achieve your business objectives more efficiently or effectively. The right consultant should offer a good return on investment by providing insights that lead to successful outcomes.

Be wary of consultants who promise quick fixes or unrealistically low fees. High-quality consultancy services require an investment, but they should also deliver significant value in return.

Checking References and Testimonials

Before finalizing your decision, it's advisable to check references and testimonials from previous clients. This can provide insights into the consultant's reliability, work ethic, and ability to deliver results. Reach out to past clients to ask about their experiences and whether they would recommend the consultant for similar projects.

client testimonials

By carefully evaluating these aspects, you can make an informed decision when choosing a biotechnology consultant. With the right expertise on your side, your business will be well-positioned for success in the dynamic world of biotechnology.